Podcasts about LabCorp

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a range of exciting advancements and strategic moves that are shaping the future of healthcare. Let's start with Pfizer's efforts in pneumococcal vaccination, a testament to the ongoing battle against Streptococcus pneumoniae. With their sights set on expanding protection and combating emerging health threats, Pfizer's initiatives reflect an industry-wide commitment to adapt to microbial challenges, potentially enhancing global public health outcomes. Their work underscores the crucial role vaccines play in preventing severe infections and maintaining public health. In other news, Parabilis Medicines is making strides by eyeing public markets to bolster its phase 3 tumor drug development. This move highlights the increasing reliance on public funding to advance late-stage clinical trials, which are essential for bringing new therapies to patients. Meanwhile, Lilly's acquisition of Engage for $202 million marks a significant expansion into non-viral DNA delivery systems. These systems could address traditional gene therapy challenges, promising more effective and safer genetic medicine options. Immunovant recently decided to discontinue its first-generation FcRn inhibitor after disappointing phase 3 results. This decision illustrates the unpredictable nature of drug development, where clinical evaluations often lead companies to reassess strategies based on trial outcomes. Such pivots are part and parcel of the rigorous scientific process that drives innovation forward. The integration of artificial intelligence in drug discovery is gaining momentum. Incyte's $80 million investment to expand its AI-driven partnership with Genesis is a clear indication of AI's growing importance in optimizing drug discovery. Similarly, Bristol Myers Squibb's collaboration with Anthropics Claude highlights a broader trend of leveraging AI across R&D processes to enhance efficiency and streamline operations. Additionally, Incyte's partnership with Edison Scientific to integrate Kosmos AI across R&D workflows exemplifies AI and machine learning's growing role in enhancing oncology drug discovery processes. Enter Oorja Bio, a newcomer focusing on idiopathic pulmonary fibrosis with a $30 million launch fund. Their novel approach to tackling this debilitating condition exemplifies the innovative spirit within smaller biotech firms aiming to address unmet medical needs. Oorja Bio's efforts are part of a larger movement in biotech where new entrants are making significant impacts by targeting specific diseases with fresh perspectives. On the regulatory front, Gilead has expanded its partnership with Korean manufacturer Yuhan through a $140 million deal for active pharmaceutical ingredients. This strategic move ensures robust supply chains amid evolving regulatory standards and market demands, underscoring the importance of global partnerships in maintaining drug availability and quality. Turning our attention to oncology, the American Society of Clinical Oncology (ASCO) 2026 conference is poised to be a significant event for industry professionals. The focus this year includes precision oncology and evolving trial designs, particularly for pancreatic cancer. The complexity of oncology studies demands tailored solutions for efficacy and regulatory compliance, pushing toward more adaptive and patient-centric trial designs. City of Hope's participation at ASCO emphasizes collaborative efforts in cancer research, combining cutting-edge science with comprehensive patient care to translate breakthroughs into tangible improvements in outcomes. Labcorp's involvement further underscores precision oncology's role through biomarker-driven trials and companion diagnostic development. The conversation at ASCO 2026 will also explore the future design of pancreatic cancer trials. By incorporating external controls and real-world data, researchers aim to streamline processes and expedite access to new therapies, acknowledging pancreatic cancer's unique challenges. In other significant advancements, UCB's Bimzelx showed superior efficacy over Skyrizi in treating psoriatic arthritis during a Phase 3 trial. As an IL-17A/IL-17F inhibitor, Bimzelx represents a promising biologic therapy option, potentially setting new standards in autoimmune treatment. Roche's voluntary license agreement with Medicines Patent Pool for Xofluza accessibility highlights efforts towards global health equity, ensuring essential medications reach low- and middle-income countries. Finally, financial movements such as Mentari Therapeutics' reverse merger raise substantial capital for neurological therapies, exemplifying ongoing investment confidence within the sector. These stories collectively illustrate an era marked by scientific innovation, strategic partnerships, and technological integration aimed at improving patient care and accelerating drug development pathways. As we continue to explore these advancements on Pharma Daily, stay tuned for more insights into how these developments shape our industry's future. That's all for today's episode of Pharma Daily. Thank you for tuning in as we navigate through these transformative times in pharmaceuticals and biotechnology.Support the show

May and Tim revisit her long COVID journey with a real progress update. After exponentially climbing spike protein antibody levels (12,000+ on LabCorp's quantitative test), autoimmune symptoms, and MCAS flares, May has finally turned a corner — and she walks listeners through what's working and why. Topics covered in this episode: Why the LabCorp quantitative spike antibody test (~$69) is more useful than Quest, which caps out at 2,500 What “normal” post-infection or post-vaccination antibody levels should look like vs. climbing pathological levels Why differentiating between vaccine-induced and infection-induced spike may matter less now, given widespread re-exposure and shedding The autoimmune and MCAS face of spikeopathy that doesn't get enough press compared to cardiorespiratory and clotting presentations The peptide protocol making the biggest difference for May, including dosing approach and cycling considerations How AI tools can help schedule complex supplement and peptide stacks Why May is layering insights from Peter McCullough (nattokinase), Tina Peers (NAC), Sabine Hazan (microbiome), and Tyler Panzner (genetics) rather than chasing one protocol Warning signs to watch for when evaluating influencers and “miracle cure” claims (nicotine patches, single-fix narratives) Why Tim believes post-COVID spikeopathy will be a larger long-term public health issue than the acute pandemic itself How to find a clinician who looks at the whole picture (genetics, epigenetics, microbiome, baseline labs) If you've been told “it can't be COVID” or you're chasing weird, unexplained symptoms that don't add up, this episode is for you. Links & Resources McCullough Foundation: https://www.mcculloughfnd.org/ Email the show: doc@bsfreemd.com  Previous BS Free MD episodes with Dr. Peter McCullough on spike protein and long COVID Previous BS Free MD episode with Dr. Tyler Panzner on genetics and epigenetics Disclaimer The information shared on BS Free MD is for educational and informational purposes only and does not constitute medical advice. Listening to this episode does not create a doctor-patient relationship. Every person's health situation is unique — what worked for May may not be appropriate for you. Always consult a qualified healthcare provider before starting, stopping, or changing any treatment, supplement, peptide, or medication. The opinions expressed are those of the hosts and guests and do not reflect the views of any affiliated organization.

Cybersecurity threats are becoming more sophisticated, and research sites are not immune. In this episode, Jimmy Bechtel sits down with Anders Lindquist, Senior Manager of Research Site Enablement at LabCorp, to break down the most pressing digital security risks facing clinical research sites today. Anders shares how human behavior is at the core of most cyber breaches, what red flags to watch for in emails and text messages, and the practical steps sites can take right now to strengthen their defenses, even with limited resources. From phishing simulations to multi-factor authentication, this conversation is a must-listen for anyone looking to better protect their site and the patients they serve.

This episode recorded live at the Becker's 16th Annual Meeting features Dr. Stephen Master, MD, PhD, Vice Chair for Innovation, Department of Pathology and Laboratory Medicine, Director, CHOP Center for Diagnostic Innovation, CHOP, Dr. Deborah Boles, PhD, Vice President, Research & Development, Labcorp, & Dr. Mindy Nye, PhD, MT (ASCP), D (ABMM), Vice President, Labcorp Diagnostics, Labcorp, who discuss how collaboration is accelerating diagnostic innovation and expanding access to pediatric care. They explore how shared infrastructure, aligned missions, and co-development models enable scalable, high-impact solutions for patients.This episode is sponsored by Labcorp.

Precision oncology promises more data, more insight, and better decisions, yet in practice it often brings more complexity. In a new episode Rafael Rosengarten is joined by Dr. Shakti Ramkissoon, VP of Oncology at Labcorp, to unpack the realities on the ground. From access gaps, reimbursement challenges and fragmented workflows to the promise of longitudinal data and AI-enabled clarity, Dr. Ramkissoon shares how Labcorp is working to simplify complexity while preserving what matters most: human connection in care.⁠⁠⁠⁠TPM E55 highlights >⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Episode 55 links:Pulse of the Oncologist 2026 reportShakti Ramkissoon on LinkedIn

Encore Presentations of Dr. Kelly & Steve House HOUR 1 from February 19, 2026 Hour 1 of https://RushToReason.com opens with a bold challenge: are we being told the full truth about our health—or just the convenient version? John Rush is joined by Dr. Kelly Victory, an independent physician and nationally recognized public health expert, for a wide-ranging and provocative conversation. Should some prescription drugs—like antibiotics—be available over the counter? Would it lower costs and restore patient freedom, or create new risks? Then the discussion pivots to hormone replacement therapy. Is declining testosterone or estrogen just “normal aging,” or are people suffering unnecessarily? And how do you pursue hormone therapy safely—without falling for clinic hype? The hour turns more intense as they examine rising cancer rates, particularly in younger adults. Is it a coincidence, lifestyle, COVID itself, or the mRNA shots? Dr. Kelly outlines concerns about immune disruption, lipid nanoparticles, and batch inconsistencies. What can people do now? Are antibody tests and certain supplements worth considering? If you've ever felt like key details are missing from the mainstream narrative, this episode asks the hard questions—without apology. Websites Mentioned * https://LabCorp.com * https://howbadismybatch.com HOUR 2 from March 12, 2026 Hour 1 of Rush to Reason delves into a wide-ranging, provocative discussion of health, vaccines, and the unanswered medical questions many Americans are asking. John Rush is joined by Dr. Kelly Victory and Steve House as they explore reports that severe cardiac events among younger Americans are rising. What exactly is driving the increase? And why are doctors and policymakers seemingly reluctant to investigate the issue more aggressively? The conversation examines the difference between traditional heart attacks and sudden cardiac death, along with growing concerns about myocarditis, spike proteins, and the long-term effects of mRNA technology. Listeners ask whether an “off switch” for mRNA might exist—and what testing options are available for those who want to know their risk. From antibody testing and D-dimer blood tests to supplements that may reduce spike proteins, the panel tackles listener questions head-on while urging caution about online medical claims. The hour also explores the safety of vaccines like flu shots and Shingrix, the integrity of the blood supply, and whether hormone replacement therapy could help aging men and women regain vitality. Are Americans getting the full story from the medical establishment—or are critical questions still going unanswered? Website Mentioned https://www.labcorp.com/

Encore Presentations of Dr. Kelly & Steve House HOUR 1 from February 19, 2026 Hour 1 of https://RushToReason.com opens with a bold challenge: are we being told the full truth about our health—or just the convenient version? John Rush is joined by Dr. Kelly Victory, an independent physician and nationally recognized public health expert, for a wide-ranging and provocative conversation. Should some prescription drugs—like antibiotics—be available over the counter? Would it lower costs and restore patient freedom, or create new risks? Then the discussion pivots to hormone replacement therapy. Is declining testosterone or estrogen just “normal aging,” or are people suffering unnecessarily? And how do you pursue hormone therapy safely—without falling for clinic hype? The hour turns more intense as they examine rising cancer rates, particularly in younger adults. Is it a coincidence, lifestyle, COVID itself, or the mRNA shots? Dr. Kelly outlines concerns about immune disruption, lipid nanoparticles, and batch inconsistencies. What can people do now? Are antibody tests and certain supplements worth considering? If you've ever felt like key details are missing from the mainstream narrative, this episode asks the hard questions—without apology. Websites Mentioned * https://LabCorp.com * https://howbadismybatch.com HOUR 2 from March 12, 2026 Hour 1 of Rush to Reason delves into a wide-ranging, provocative discussion of health, vaccines, and the unanswered medical questions many Americans are asking. John Rush is joined by Dr. Kelly Victory and Steve House as they explore reports that severe cardiac events among younger Americans are rising. What exactly is driving the increase? And why are doctors and policymakers seemingly reluctant to investigate the issue more aggressively? The conversation examines the difference between traditional heart attacks and sudden cardiac death, along with growing concerns about myocarditis, spike proteins, and the long-term effects of mRNA technology. Listeners ask whether an “off switch” for mRNA might exist—and what testing options are available for those who want to know their risk. From antibody testing and D-dimer blood tests to supplements that may reduce spike proteins, the panel tackles listener questions head-on while urging caution about online medical claims. The hour also explores the safety of vaccines like flu shots and Shingrix, the integrity of the blood supply, and whether hormone replacement therapy could help aging men and women regain vitality. Are Americans getting the full story from the medical establishment—or are critical questions still going unanswered? Website Mentioned https://www.labcorp.com/

What happens when Lyme disease is repeatedly dismissed even when the symptoms are clear? In this episode of Integrative Lyme Solutions, Dr. K speaks with Lyme advocate Amy Rose, who spent more than eight years searching for answers after being infected by a tick bite in 2008. Within days she developed severe flu-like symptoms and later discovered a large bullseye rash on her shoulder. Despite these classic warning signs, doctors repeatedly told her Lyme disease was impossible because she had been bitten in Arkansas. Multiple tests came back negative and she was given numerous misdiagnoses and medications instead of answers. Amy shares how her health continued to decline while she saw 27 doctors before finally receiving a proper diagnosis from a Lyme-literate practitioner. She also explains how this experience led her to start the Arkansas Lyme Foundation to support patients in a state where Lyme disease is still widely denied. Her story reveals the serious gaps in Lyme testing, the consequences of misdiagnosis, and the power of patient advocacy. Key Takeaways: 0:00 Introduction 2:15 Amy Rose's Lyme infection and early symptoms in 2008 6:40 The bullseye rash and why Lyme was still missed 10:30 Five negative tests through Labcorp and misdiagnosis 16:50 Neurological Lyme and being misdiagnosed with Alzheimer's 22:10 Losing the ability to drive due to brain inflammation 26:30 Finding a Lyme-literate doctor after seeing 27 physicians 32:45 Starting the Arkansas Lyme Foundation 38:20 Why Arkansas still denies Lyme disease exists 44:15 Reaching remission and focusing on cellular health and mold detox Resources Mentioned: Arkansas Lyme Foundation - https://www.arkansaslyme.org/ Labcorp - https://www.labcorp.com/ Medical Disclaimer: This content is for educational purposes only and is not intended to diagnose, treat, cure, or replace professional medical advice. Always consult your physician or qualified healthcare provider regarding any medical condition or treatment decisions. _______________________________The Karlfeldt Center offers the most cutting-edge and comprehensive Lyme therapies. To schedule a Free 15-Minute Discovery Call with a Lyme Literate Naturopathic Doctor at The Karlfeldt Center, call 208-338-8902 or email info@TheKarlfeldtCenter.comCheck out Dr. K's Ebook: Breaking Free From Lyme: A Comprehensive Guide to Healing and Recovery here: https://store.thekarlfeldtcenter.com/products/breaking-free-from-lymeUse the code LYMEPODCAST for a 100% off discount!

✨ Go to my sponsor https://trylco.com/stellarae and use code stellarae to get 20% off select tests - Get the insights you need to live a healthier life spring is the real new year, and this season is the perfect time to reset your mindset, your habits, and the direction of your life.in today's episode of the stellaray podcast, i'm talking about how to actually step into alignment this spring and why mindset, action, and intuition all have to work together if you want to create real change.i also open up about one of the hardest periods of my life after moving to new york, how i got out of a toxic and abusive relationship, and the mindset shifts that helped me rebuild my confidence and move forward.if you're trying to reset your life, level up this spring, or get out of a difficult situation, this episode is for you.subscribe to the podcast if you want more episodes about mindset, self-growth, wellness, relationships, and becoming your best self.enjoy & dont forget to tweet/ig story me a screenshot of you listening!✨Get up to 10 free meals and free breakfast for LIFE with HelloFresh! Use code HF-0449 https://www.filify.co/SHBn0 ✨Get 20% off LabCorp tests with code stellarae https://trylco.com/stellarae ✨Get a free 10 pack of manuka honey sticks from Manukora with code STELLA https://manukora.com/STELLAMY NEW WEBSITE!! Shop merch, sign up for my newsletter, book a coffee chat, & more: http://stellaraeherself.comGet $1000 off the health coach certification program I'm doing with promo code STELLACOACHING https://www.shareasale.com/u.cfm?d=1281553&m=96296&u=1030263I edit using Riverside! https://www.riverside.fm/?utm_campaign=campaign_5&utm_medium=affiliate&utm_source=rewardful&via=stella-holtinstagram http://instagram.com/stellaraepodcastlisten to and/or support the podcast: https://anchor.fm/stella-raetiktok: http://tiktok.com/@stellaraeherselftwitter: http://twitter.com/stellaraegoodreads: https://www.goodreads.com/user/show/10449999-stella-raemy fav books/products/health: https://www.amazon.com/shop/stellaraemy current filming set up:camera: https://amzn.to/4cEQiLOmicrophone: https://amzn.to/3Z2A5gctripod: https://amzn.to/3AEmxgKring light: https://amzn.to/3XxZrShbox lights: https://amzn.to/4e1Q1Ubportable light for phone: https://amzn.to/3XxZspjlisten on spotify: https://open.spotify.com/show/2DMbeh7EqiqgROIjvW0sI9listen on apple podcasts: https://podcasts.apple.com/us/podcast/the-stella-rae-podcast/id125561818200:00 why the real new year starts in spring01:05 using every experience as energy for growth02:10 the mindset shift that changes everything02:45 why people are so flaky today04:00 the real reason we avoid things we want05:30 pushing through discomfort and anxiety06:50 feminine energy vs discipline (you need both)08:20 how the universe aligns opportunities09:10 staying locked in with food10:30 how i ended up in a dark place after moving to new york11:20 being in an abusive relationship and losing myself12:20 the moment i knew i had to leave13:10 why toxic relationships can feel addictive14:00 how friends and family helped me get out15:10 rebuilding confidence and energy after leaving16:00 the biggest lesson i learned from that time17:00 trusting your intuition and aligning with your values18:00 recognizing opportunities and taking action19:10 how living in new york changed my mindset20:20 easy health testing21:10 encouragement if you're going through a hard time21:45 spring lock-in habits and wellness routines22:40 love story on hulu recap + relationship dynamics24:00 the problem with people pleasing in relationships25:00 why the show feels like a cautionary tale#StellaRaePodcast

The US war on Iran continues to create an emergency for the working class worldwide, and we start by discussing the need for workers to enter the struggle to end it. We've got headlines this week from LabCorp, Mercedes, JBS, Home Depot, DHL Express, Patagonia, Crumbs & Whiskers and The Holy Donut. For our first full story, we discuss the ongoing strike by teachers in Sacramento. Next, yet another story has come out revealing a new smart device's "AI" features are actually just poorly paid remote workers. Florida is taking yet another major step in its war on public unions. Finally, we discuss how workers continue to fight against Gestapo terror here in the belly of the beast. Join the discord: discord.gg/tDvmNzX  Follow the pod at instagram.com/workstoppage, @WorkStoppagePod on Twitter,  John @facebookvillain, and Lina @solidaritybee

Encore Presentation of Hour 1 for February 12, 2026 HOUR 1 Hour 1 of Rush To Reason opens with intensity as John Rush is joined by Dr. Kelly Victory, an independent physician known for challenging mainstream medical narratives. Together, they tackle explosive questions about medical ethics, patient trust, and whether ideology is creeping into health care decisions. Can patients be treated differently based on political beliefs—and who holds providers accountable if that happens? The conversation pivots to a disturbing trend: the sharp rise in aggressive colon cancer among adults under 50. Why now? Dr. Victory breaks down immune dysfunction, delayed screening guidelines, and why early detection may matter more than ever. They also explore vaccines through a strict risk-versus-benefit lens, questioning long-term effects, unresolved scientific gaps, and why so many questions were never answered before mandates rolled out. As the hour closes, the focus shifts to personal choice versus government control, including whether states should set their own vaccine rules—and what that could mean for families deciding where to live. Is the public finally asking the questions it should have asked years ago? Encore Presentation of Hour 1 for February 12, 2026 HOUR 2 Hour 1 of https://RushToReason.com opens with a bold challenge: are we being told the full truth about our health—or just the convenient version? John Rush is joined by Dr. Kelly Victory, an independent physician and nationally recognized public health expert, for a wide-ranging and provocative conversation. Should some prescription drugs—like antibiotics—be available over the counter? Would it lower costs and restore patient freedom, or create new risks? Then the discussion pivots to hormone replacement therapy. Is declining testosterone or estrogen just “normal aging,” or are people suffering unnecessarily? And how do you pursue hormone therapy safely—without falling for clinic hype? The hour turns more intense as they examine rising cancer rates, particularly in younger adults. Is it a coincidence, lifestyle, COVID itself, or the mRNA shots? Dr. Kelly outlines concerns about immune disruption, lipid nanoparticles, and batch inconsistencies. What can people do now? Are antibody tests and certain supplements worth considering? If you've ever felt like key details are missing from the mainstream narrative, this episode asks the hard questions—without apology. Websites Mentioned * https://LabCorp.com * https://howbadismybatch.com

Encore Presentation of Hour 1 for February 12, 2026 HOUR 1 Hour 1 of Rush To Reason opens with intensity as John Rush is joined by Dr. Kelly Victory, an independent physician known for challenging mainstream medical narratives. Together, they tackle explosive questions about medical ethics, patient trust, and whether ideology is creeping into health care decisions. Can patients be treated differently based on political beliefs—and who holds providers accountable if that happens? The conversation pivots to a disturbing trend: the sharp rise in aggressive colon cancer among adults under 50. Why now? Dr. Victory breaks down immune dysfunction, delayed screening guidelines, and why early detection may matter more than ever. They also explore vaccines through a strict risk-versus-benefit lens, questioning long-term effects, unresolved scientific gaps, and why so many questions were never answered before mandates rolled out. As the hour closes, the focus shifts to personal choice versus government control, including whether states should set their own vaccine rules—and what that could mean for families deciding where to live. Is the public finally asking the questions it should have asked years ago? Encore Presentation of Hour 1 for February 12, 2026 HOUR 2 Hour 1 of https://RushToReason.com opens with a bold challenge: are we being told the full truth about our health—or just the convenient version? John Rush is joined by Dr. Kelly Victory, an independent physician and nationally recognized public health expert, for a wide-ranging and provocative conversation. Should some prescription drugs—like antibiotics—be available over the counter? Would it lower costs and restore patient freedom, or create new risks? Then the discussion pivots to hormone replacement therapy. Is declining testosterone or estrogen just “normal aging,” or are people suffering unnecessarily? And how do you pursue hormone therapy safely—without falling for clinic hype? The hour turns more intense as they examine rising cancer rates, particularly in younger adults. Is it a coincidence, lifestyle, COVID itself, or the mRNA shots? Dr. Kelly outlines concerns about immune disruption, lipid nanoparticles, and batch inconsistencies. What can people do now? Are antibody tests and certain supplements worth considering? If you've ever felt like key details are missing from the mainstream narrative, this episode asks the hard questions—without apology. Websites Mentioned * https://LabCorp.com * https://howbadismybatch.com

If you're a woman in your 50s or 60s who has been doing all the right things, eating well, moving your body, managing stress, and yet you still find yourself wondering if there is more you could be doing to protect your health for the long run, this episode is for you. In this conversation on Pleasure in the Pause, host Gabriella Espinosa sits down with Dr. Noor Al-Humaidhi, a board-certified family physician, menopause specialist, and founder of Lifestyles by Noor, to build what Gabriella calls the Midlife Vitality Blueprint. This is not about living longer. This is about living stronger, with vitality, confidence, and energy for the next 20, 30, even 40 years. Because midlife is not the beginning of decline. It is the beginning of design.Dr Noor Al-Humaidhi is a Board Certified Family Physician and Menopause Society Certified Practitioner.  She is affectionately known as Dr Noor in the community. She grew up in Kuwait before attending medical school in Dublin, Ireland. She then moved to the UK where she trained in General Practice and started her career. She moved to the Seacoast 7 years ago to be nearer to family and restarted her family practice career after overcoming the hurdles of Board certification here in the US. After her own experience with perimenopause coupled with her difficulty accessing care she founded Lifestyles by Noor. Lifestyles is a midlife wellness destination practice. Her aim is to arm clients with the data that they need to maximize their health span. She has a particular focus on women in perimenopause and menopause who are having difficulty accessing appropriate care to manage their symptoms. Her goal is to educate, empower and help clients feel their best. Highlights from our discussion include:Why lifting heavy weights (40, 50, 60 pounds and beyond) is the single most important lifestyle intervention.The essential labs that most doctors don't run.How to advocate for hormone therapy after age 60.The metabolic syndrome of menopause.Why DEXA scans should start at age 35, not 60.CONNECT WITH Dr. Noor:Website Personal | PracticeInstagramResources:Estrogen Matters by Avrum Bluming and Carol TavrisThe Menopause SocietyLet's Talk MenopauseQuest Diagnostics or LabCorp for labsCONNECT WITH GABRIELLA ESPINOSA:InstagramLinkedInWork with Gabriella!  Go to https://www.gabriellaespinosa.com/ to book a call.Full episodes on YouTube. The information shared on Pleasure in the Pause is for educational and informational purposes only and is not intended as medical advice. Always consult your healthcare provider before making any decisions about your health or treatment. The views expressed by guests are their own and do not necessarily reflect the views of the host or Pleasure in the Pause.

Join the Conversation at 303-477-5600 or text to 307-200-8222 Monday - Friday from 3 pm - 6 pm MT. HOUR 1 Hour 1 of https://RushToReason.com opens with a bold challenge: are we being told the full truth about our health—or just the convenient version? John Rush is joined by Dr. Kelly Victory, an independent physician and nationally recognized public health expert, for a wide-ranging and provocative conversation. Should some prescription drugs—like antibiotics—be available over the counter? Would it lower costs and restore patient freedom, or create new risks? Then the discussion pivots to hormone replacement therapy. Is declining testosterone or estrogen just “normal aging,” or are people suffering unnecessarily? And how do you pursue hormone therapy safely—without falling for clinic hype? The hour turns more intense as they examine rising cancer rates, particularly in younger adults. Is it a coincidence, lifestyle, COVID itself, or the mRNA shots? Dr. Kelly outlines concerns about immune disruption, lipid nanoparticles, and batch inconsistencies. What can people do now? Are antibody tests and certain supplements worth considering? If you've ever felt like key details are missing from the mainstream narrative, this episode asks the hard questions—without apology. Websites Mentioned * https://LabCorp.com * https://howbadismybatch.com HOUR 2 Hour 2 turns up the heat. John Rush welcomes Alvin Louie, President of Courage Is a Habit, for a tactical breakdown of what he calls “language deconstruction.” Are cultural debates—especially around transgender ideology—being won not by facts, but by redefining words? Alvin shares a provocative role-play and a six-month social experiment designed to expose what he believes are manipulative debate tactics. How do you avoid getting dragged into the “swamp” and losing moral clarity? Then John pivots to media accountability. With the FCC reportedly scrutinizing The View over equal-time rules, what exactly is the Fairness Doctrine—and could it apply to late-night hosts, too? If one political candidate gets airtime, should the opponent automatically get the same? The hour closes with strong commentary on circumcision, religious doctrine, and a viral controversy involving an Islamic scholar condemning dog ownership. Are we witnessing cultural confusion—or a deeper ideological shift? If you care about free speech, faith, media bias, and parental authority, this hour demands your attention. Guest Timestamps * 1:17 – Alvin Louie - https://courageisahabit.org HOUR 3 Hour 3 opens with Jerzee Joe delivering a sharp economic perspective: Why do nations with the same geography end up worlds apart economically? From Haiti vs. the Dominican Republic to East vs. West Berlin, is government the defining factor between prosperity and collapse? The conversation intensifies with analysis of media silence surrounding controversial political rhetoric, questions about crime trends, and ongoing investigations tied to Black Lives Matter leadership. Are Americans getting the full story—or just curated headlines? Then, energy policy takes center stage as Kenny Stein, Vice President of Policy at the American Energy Alliance and the Institute for Energy Research, joins the program. What did the Trump administration actually roll back in EPA regulations? Were EV mandates quietly being imposed through regulatory backdoors? Why are hybrid vehicles outperforming fully electric models in a true free-market environment? And did Toyota outsmart Detroit by refusing to chase political trends? From governance and urban decline to energy freedom and the realities of the auto industry, this hour challenges narratives and asks: What happens when policy overrides the marketplace? Guest Timestamps * 1:08 – Jerzee Joe: @ https://www.jerzeejoe.com * 25:13 – Kenny Stein @ https://www.americanenergyalliance.org/ & https://www.instituteforenergyresearch.org

Join the Conversation at 303-477-5600 or text to 307-200-8222 Monday - Friday from 3 pm - 6 pm MT. HOUR 1 Hour 1 of https://RushToReason.com opens with a bold challenge: are we being told the full truth about our health—or just the convenient version? John Rush is joined by Dr. Kelly Victory, an independent physician and nationally recognized public health expert, for a wide-ranging and provocative conversation. Should some prescription drugs—like antibiotics—be available over the counter? Would it lower costs and restore patient freedom, or create new risks? Then the discussion pivots to hormone replacement therapy. Is declining testosterone or estrogen just “normal aging,” or are people suffering unnecessarily? And how do you pursue hormone therapy safely—without falling for clinic hype? The hour turns more intense as they examine rising cancer rates, particularly in younger adults. Is it a coincidence, lifestyle, COVID itself, or the mRNA shots? Dr. Kelly outlines concerns about immune disruption, lipid nanoparticles, and batch inconsistencies. What can people do now? Are antibody tests and certain supplements worth considering? If you've ever felt like key details are missing from the mainstream narrative, this episode asks the hard questions—without apology. Websites Mentioned * https://LabCorp.com * https://howbadismybatch.com HOUR 2 Hour 2 turns up the heat. John Rush welcomes Alvin Louie, President of Courage Is a Habit, for a tactical breakdown of what he calls “language deconstruction.” Are cultural debates—especially around transgender ideology—being won not by facts, but by redefining words? Alvin shares a provocative role-play and a six-month social experiment designed to expose what he believes are manipulative debate tactics. How do you avoid getting dragged into the “swamp” and losing moral clarity? Then John pivots to media accountability. With the FCC reportedly scrutinizing The View over equal-time rules, what exactly is the Fairness Doctrine—and could it apply to late-night hosts, too? If one political candidate gets airtime, should the opponent automatically get the same? The hour closes with strong commentary on circumcision, religious doctrine, and a viral controversy involving an Islamic scholar condemning dog ownership. Are we witnessing cultural confusion—or a deeper ideological shift? If you care about free speech, faith, media bias, and parental authority, this hour demands your attention. Guest Timestamps * 1:17 – Alvin Louie - https://courageisahabit.org HOUR 3 Hour 3 opens with Jerzee Joe delivering a sharp economic perspective: Why do nations with the same geography end up worlds apart economically? From Haiti vs. the Dominican Republic to East vs. West Berlin, is government the defining factor between prosperity and collapse? The conversation intensifies with analysis of media silence surrounding controversial political rhetoric, questions about crime trends, and ongoing investigations tied to Black Lives Matter leadership. Are Americans getting the full story—or just curated headlines? Then, energy policy takes center stage as Kenny Stein, Vice President of Policy at the American Energy Alliance and the Institute for Energy Research, joins the program. What did the Trump administration actually roll back in EPA regulations? Were EV mandates quietly being imposed through regulatory backdoors? Why are hybrid vehicles outperforming fully electric models in a true free-market environment? And did Toyota outsmart Detroit by refusing to chase political trends? From governance and urban decline to energy freedom and the realities of the auto industry, this hour challenges narratives and asks: What happens when policy overrides the marketplace? Guest Timestamps * 1:08 – Jerzee Joe: @ https://www.jerzeejoe.com * 25:13 – Kenny Stein @ https://www.americanenergyalliance.org/ & https://www.instituteforenergyresearch.org

Join the Conversation at 303-477-5600 or text to 307-200-8222 Monday - Friday from 3 pm - 6 pm MT. HOUR 1 Hour 1 of https://RushToReason.com opens with a bold challenge: are we being told the full truth about our health—or just the convenient version? John Rush is joined by Dr. Kelly Victory, an independent physician and nationally recognized public health expert, for a wide-ranging and provocative conversation. Should some prescription drugs—like antibiotics—be available over the counter? Would it lower costs and restore patient freedom, or create new risks? Then the discussion pivots to hormone replacement therapy. Is declining testosterone or estrogen just “normal aging,” or are people suffering unnecessarily? And how do you pursue hormone therapy safely—without falling for clinic hype? The hour turns more intense as they examine rising cancer rates, particularly in younger adults. Is it a coincidence, lifestyle, COVID itself, or the mRNA shots? Dr. Kelly outlines concerns about immune disruption, lipid nanoparticles, and batch inconsistencies. What can people do now? Are antibody tests and certain supplements worth considering? If you've ever felt like key details are missing from the mainstream narrative, this episode asks the hard questions—without apology. Websites Mentioned * https://LabCorp.com * https://howbadismybatch.com HOUR 2 Hour 2 turns up the heat. John Rush welcomes Alvin Louie, President of Courage Is a Habit, for a tactical breakdown of what he calls “language deconstruction.” Are cultural debates—especially around transgender ideology—being won not by facts, but by redefining words? Alvin shares a provocative role-play and a six-month social experiment designed to expose what he believes are manipulative debate tactics. How do you avoid getting dragged into the “swamp” and losing moral clarity? Then John pivots to media accountability. With the FCC reportedly scrutinizing The View over equal-time rules, what exactly is the Fairness Doctrine—and could it apply to late-night hosts, too? If one political candidate gets airtime, should the opponent automatically get the same? The hour closes with strong commentary on circumcision, religious doctrine, and a viral controversy involving an Islamic scholar condemning dog ownership. Are we witnessing cultural confusion—or a deeper ideological shift? If you care about free speech, faith, media bias, and parental authority, this hour demands your attention. Guest Timestamps * 1:17 – Alvin Louie - https://courageisahabit.org HOUR 3 Hour 3 opens with Jerzee Joe delivering a sharp economic perspective: Why do nations with the same geography end up worlds apart economically? From Haiti vs. the Dominican Republic to East vs. West Berlin, is government the defining factor between prosperity and collapse? The conversation intensifies with analysis of media silence surrounding controversial political rhetoric, questions about crime trends, and ongoing investigations tied to Black Lives Matter leadership. Are Americans getting the full story—or just curated headlines? Then, energy policy takes center stage as Kenny Stein, Vice President of Policy at the American Energy Alliance and the Institute for Energy Research, joins the program. What did the Trump administration actually roll back in EPA regulations? Were EV mandates quietly being imposed through regulatory backdoors? Why are hybrid vehicles outperforming fully electric models in a true free-market environment? And did Toyota outsmart Detroit by refusing to chase political trends? From governance and urban decline to energy freedom and the realities of the auto industry, this hour challenges narratives and asks: What happens when policy overrides the marketplace? Guest Timestamps * 1:08 – Jerzee Joe: @ https://www.jerzeejoe.com * 25:13 – Kenny Stein @ https://www.americanenergyalliance.org/ & https://www.instituteforenergyresearch.org

Some birth stories don't go the way anyone expects, and Hannah's is one that every expectant parent deserves to hear. In this episode of The Birth Lounge, Hannah joins us to share her experience of developing preeclampsia and giving birth at 28 weeks, despite having what looked like a completely normal pregnancy. She walks us through the early signs that were easy to miss, the moment everything shifted, and what it was like to suddenly find herself navigating a NICU stay she never saw coming. Together, we talk about why preeclampsia can feel so shocking, how often it's missed or caught late, and why first trimester placental screening has the potential to change outcomes. Hannah shares what she wishes she had known sooner, what helped her advocate within the medical system, and how early detection could have altered her experience. This conversation also offers practical, heartfelt support for NICU parents and the people who love them. Hannah shares what actually helped during her NICU journey, how relationships can shift under that kind of stress, and what meaningful support really looks like when a baby arrives early. We also explore emerging tools like the Encompass test, the role of baby aspirin, and how global practices around placental screening differ from what's commonly offered in the U.S. This episode isn't about fear, it's about awareness, advocacy, and the belief that parents deserve better information earlier. If you're pregnant, planning a pregnancy, or supporting someone through a high-risk experience, this episode will leave you feeling more informed, more empowered, and less alone. Guest Bio: Hannah is a NICU mom turned maternal health advocate. After developing severe preeclampsia at 28 weeks, she delivered her daughter three months early to save both of their lives. Now, Hannah shares what she wishes she had known so other parents don't have to be blindsided by a diagnosis they were never truly prepared for. SOCIAL MEDIA: Connect with HeHe on Instagram  Connect with Hannah on IG    BIRTH EDUCATION: Join The Birth Lounge for judgment-free, evidence-based childbirth education that shows you exactly how to navigate hospital policies, avoid unnecessary interventions, and have a trauma-free labor experience, all while feeling wildly supported every step of the way Want prep delivered straight to your phone? Download The Birth Lounge App for bite-sized birth and postpartum tools you can use anytime, anywhere. And if you haven't grabbed it yet… Snag my free Pitocin Guide to understand the risks, benefits, and red flags your provider may not be telling you about, so you can make informed, powerful decisions in labor.   LINKS/RESOURCES: If the NICU has touched your story, our NICU Support & Survival playlist on YouTube is there to hold space with honest conversations and supportive guidance.   These are the NICU outfits from Luxie Charm Hannah mentioned!    Learn more about why first trimester preeclampsia screening matters. This short video from Labcorp breaks down the importance of early, blood-based screening across pregnancy and how earlier insight can change outcomes for families: https://womenshealth.labcorp.com/preeclampsia-risk-assessment-across-all-trimesters-using-blood-based-biochemical-markers Support making early screening the standard of care: Hannah has started a petition advocating for first trimester preeclampsia risk screening to be included in routine prenatal care in the U.S., helping protect parents before they're ever blindsided: https://www.change.org/p/make-first-trimester-risk-screening-part-of-standard-prenatal-care-in-the-u-s  

Which care models will handle the scourge of metabolic disorders? Beyond the societal questions raised by this public health phenomenon, the real concern is whether traditional care models are capable of managing this group of conditions effectively and sustainably. This largely because traditional care models are episodic and put little focus on behaviour change that is dearly needed to reverse the trend. Among those who have realized it and are striving for alternatives, Ihsan Almarzooqi and his team at meta[bolic] stand out. Based in Dubai, they have developed and deployed a unique care model, which they aim to replicate in Europe, starting with the UK. Their approach blends cutting-edge diagnostics, remote monitoring, and a care pathway involving frequent interactions with medical staff—enough to drive long-term behavioural change. And its efficacy has been demonstrated through numerous studies published since its inception. Beyond this hybrid care model, what is striking about Ihsan and the meta[bolic] philosophy is their relentless focus on improving outcomes for patients and incorporating the latest care innovations to raise the bar. Up to the point of reducing their operational margin to extend their knowledge of each patient, as long as it improves the level of care. In this episode, we discuss what makes this care pathway unique, its implementation, the results, and how we can leverage traditional reimbursement schemes while still delivering a continuous and outcome-oriented care experience. An inspiring and thought-provoking conversation on what care models for metabolic disorders can be, despite the constraints posed by most health systems! Timeline: 00:00:00 - What led Ihsan to pioneer new care delivery models 00:06:03 - The extent of the metabolic diseases pandemic 00:10:39 - Why traditional care models fail to address metabolic diseases 00:16:49 - The components that make up the meta[bolic] care model 00:23:37 - How the meta[bolic] care model is funded in the UAE 00:30:57 - Ihsan's philosophy about evidence generation and how it is lived at meta[bolic] 00:33:28 - Scaling the meta[bolic] model to other geographies beyond the UAE 00:38:45 - How to keep patients engaged throughout their care journey 00:41:55 - Ihsan's wishes for the democratization of value-based care What we also talked about with Ihsan: Continuous glucose monitors (CGMs) GLP-1 agonists Labcorp p-Tau217 VO2 max test PromarkerD test As mentioned by Ihsan during the episode, you can have a read at Ground Truths by Dr. Eric Topol and his recent book Super Agers, an encyclopedia of the latest medical knowledge around longevity. Ihsan also recommends listening to Dr. Peter Attia's podcast The Drive, which investigates everything from exercise and nutritional biochemistry to cardiovascular health, cancer, cognitive health, mental and emotional well-being, and beyond. You may also read Ihsan's publication in NEJM Catalyst Innovations in Care Delivery alongside Hala Zakaria, and Ali Hashemi, on their hybrid care model to manage diabetes in the UAE. You can get in touch with Ihsan via LinkedIn, and follow meta[bolic]'s activities on their website, LinkedIn, Facebook, Instagram, and YouTube. ✉️ If you want to give me feedback on the episode or suggest potential guests, contact me over LinkedIn or via email! ⭐️ And if you liked the episode, please share it, subscribe to the podcast, and leave a 5-star review on streaming platforms!

In this episode, Dr. Sanjai Nagendra and Cameron Thomason of Labcorp discuss how lab stewardship is evolving into a systemwide strategy to improve quality, control costs, and support population health through data, analytics, and cross functional leadership alignment.This episode is sponsored by Labcorp.

Brent Dial, Founder and CEO of Beek Health, has built a platform that addresses patient information fragmentation by aggregating data from patient portals and providing direct access to lab testing. Health literacy is key to preventing chronic diseases, and AI is being used to scale the delivery of personalized health information. Identifying relevant biomarkers and early warning signs supports proactive health management that can alter long-term health outcomes. Brent explains, "Beek Health is re-imagining healthcare by finally putting the individual at the center of their health journey. While we talk about patient-centric or customer-centric or shared decision-making, it's not real in practice, and it's for good and for very clear reasons. There's information asymmetry, there's information overload, and then information is quite fragmented." "Currently, we have three subscription tiers. The first option is the basic plan, which gives you platform access to synthesize and connect with multiple patient portals, as many as you have. The average individual has at least two patient portals, and it's estimated you'll see 17 different providers in your lifetime. So that's a lot of data spread out across different systems. So, one, you can sync. We have over 40,000 endpoints or provider locations where you can sync your patient portal information in one unified dashboard. All the dashboards look different."  "Second, you'll have access to labs anytime you need them. And so labs are woefully underutilized for health tracking: 70% of diagnoses are based on lab results, so you can access them anytime you need to. We partner with LabCorp, which has over 2,000 locations, and you'll receive your results within 48 hours. In addition, we're adding cost navigation, cost estimate tools, and some more fun features on our roadmap, but that just gives you basic access for a year for $99."   #BeekHealth #HealthInYourHands #OwnYourHealthData #HealthTech #DigitalHealth #PatientEmpowerment #HealthcareReimagined #ConnectedHealth #FutureOfHealth beekhealth.com Download the transcript here

Brent Dial, Founder and CEO of Beek Health, has built a platform that addresses patient information fragmentation by aggregating data from patient portals and providing direct access to lab testing. Health literacy is key to preventing chronic diseases, and AI is being used to scale the delivery of personalized health information. Identifying relevant biomarkers and early warning signs supports proactive health management that can alter long-term health outcomes. Brent explains, "Beek Health is re-imagining healthcare by finally putting the individual at the center of their health journey. While we talk about patient-centric or customer-centric or shared decision-making, it's not real in practice, and it's for good and for very clear reasons. There's information asymmetry, there's information overload, and then information is quite fragmented." "Currently, we have three subscription tiers. The first option is the basic plan, which gives you platform access to synthesize and connect with multiple patient portals, as many as you have. The average individual has at least two patient portals, and it's estimated you'll see 17 different providers in your lifetime. So that's a lot of data spread out across different systems. So, one, you can sync. We have over 40,000 endpoints or provider locations where you can sync your patient portal information in one unified dashboard. All the dashboards look different."  "Second, you'll have access to labs anytime you need them. And so labs are woefully underutilized for health tracking: 70% of diagnoses are based on lab results, so you can access them anytime you need to. We partner with LabCorp, which has over 2,000 locations, and you'll receive your results within 48 hours. In addition, we're adding cost navigation, cost estimate tools, and some more fun features on our roadmap, but that just gives you basic access for a year for $99."   #BeekHealth #HealthInYourHands #OwnYourHealthData #HealthTech #DigitalHealth #PatientEmpowerment #HealthcareReimagined #ConnectedHealth #FutureOfHealth beekhealth.com Listen to the podcast here

Ben, Woods, and Paul are here for you on a Wednesday morning! We start the show with a ton to get to in foreplay as we get updates on what the guys all did after the show yesterday, we discuss fresh homemade bread, and get an update on Vacuum-Gate in the Woods household! Then we set the menu for today's show before the guys discuss last night's College Football Playoff rankings, and whether or not Woodsy's Fighting Irish are in trouble? Listen here!

In der heutigen Folge sprechen die Finanzjournalisten Anja Ettel und Holger Zschäpitz über starke Zahlen von Crowdstrike, Kurssprung bei Bayer und eine wilde Wende bei Bitcoin. Außerdem geht es um Ether, Intel, xLight, Meta, Boeing, Airbus, Marvell, Celestial AI, Nvidia, Broadcom, GitLab, Adobe, Workday, DocuSign, Apple, Microsoft, MongoDB, Credo Technology, Wacker Neuson, Doosan Bobcat, Hochtief, Hypoport, Hugo Boss, Rheinmetall, Nvidia, Lockheed Martin, Hensoldt, Renk, TKMS, VW, BMW, Mercedes-Benz, Continental, Porsche, Schaeffler, Daimler Truck, Bank of America, KeyCorp, PNC Financial Services, US-Bancorp, Truist Financial, Aon, Marsh & McLennan, Willis Towers Watson, Accenture, Cognizant, EPAM Systems, IBM, Twilio, DXC Technology, SAIC, Guidewire Software, Manhattan Associates, Pegasystems, Tyler Technologies, Labcorp, IQVIA, Certara und Siemens Energy. Die aktuelle "Alles auf Aktien"-Umfrage findet Ihr unter: https://www.umfrageonline.com/c/mh9uebwm Wir freuen uns an Feedback über aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter.[ Hier bei WELT.](https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html.) [Hier] (https://open.spotify.com/playlist/6zxjyJpTMunyYCY6F7vHK1?si=8f6cTnkEQnmSrlMU8Vo6uQ) findest Du die Samstagsfolgen Klassiker-Playlist auf Spotify! Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? [**Hier findest du alle Infos & Rabatte!**](https://linktr.ee/alles_auf_aktien) Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Will and Dan record a rare live show in an unusual venue: the Salamander Resort in Middleburg, Virginia, at the annual attorney retreat for trial boutique Wilkinson Stekloff. Dan teaches Will some of the new lingo he's learned from the firm's trial experts before a deep dive into civil procedure. First, we dig into the recently argued Coney Island Auto Parts Unlimited v. Burton, which presents a seemingly easy legal question and harder questions about SCOTUS advocacy and ethics. Then we look back at last Term's LabCorp v. Davis, which the Court DIG'd but which raises some fundamental questions about class action litigation that the Court is likely to revisit down the road.  

What if a simple, affordable blood test could reveal how well your cells are functioning—and how long you're likely to live? In this episode of The Integrative Health Podcast, Dr. Jen sits down with Dr. Darren Schmidt, DC, founder of the Nutritional Healing Center of Ann Arbor, to explore the brand-new MVX Plus (Metabolic Vulnerability Index Plus) blood test and the overlooked nutrient that is foundational to human health: Vitamin B1 (Thiamine).They unpack what this test actually measures, why it's incredibly predictive of longevity, and how it helps uncover the true root cause when patients feel stuck. Dr. Schmidt also shares how high-dose fat-soluble B1 saved his life—and why modern life is silently draining this essential vitamin.Dr. Jen interviews Dr. Darren Schmidt about MVX Plus, a new low-cost LabCorp blood test that measures cellular function and predicts longevity, and why Vitamin B1 (Thiamine) is essential for mitochondrial health, nervous system repair, and chronic illness recovery.PODCAST: Thank you for listening please subscribe and share! Shop supplements: https://healthybydrjen.shop/CHECK OUT a list of my Favorite products here: https://www.healthybydrjen.com/drjenfavorites FOLLOW ME:Instagram :: https://www.instagram.com/integrativedrmom/Facebook :: https://www.facebook.com/integrativedrmomYouTube :: https://www.youtube.com/@integrativedrmom FTC: Some links included in this description might be affiliate links. If you purchase a product through one of them, I will receive a commission (at no additional cost to you). I truly appreciate your support of my channel. Thank you for watching! Video is not sponsored. DISCLAIMER: This podcast does not contain any medical or health related diagnosis or treatment advice. Content provided on this podcast is for informational purposes only. For any medical or health related advice, please consult with a physician or other healthcare professionals. Further, information about specific products or treatments within this podcast are not to diagnose, treat, cure or prevent disease.

Broadcast from KSQD, Santa Cruz on 10-30-2025: Dr. Dawn opens with Halloween-themed scary medical stories, beginning with food toxins lurking in refrigerators and pantries. She explains how molds on grains and nuts, particularly Aspergillus species, produce aflatoxins that bind to DNA and cause liver cancer, making peanuts especially risky. Fusarium on wheat produces trichothecenes and fumonisins damaging cell membranes. Penicillium molds on fruits like apples produce patulin creating reactive oxygen species that harm organs. She advises discarding soft moldy foods entirely since fungal hyphae penetrate deeply, while hard cheeses can have moldy portions cut away. Meat spoilage involves bacteria producing cadaverine and putrescine, with E. coli, Campylobacter, Salmonella, and Clostridium causing severe illness through heat-stable toxins. A caller asks about yogurt-covered peanuts tasting rancid and confirms Botox contains botulinum toxin A in different salt forms, used medically for migraines, hyperhidrosis, and strabismus. The caller also describes paper-thin skin on sun-exposed forearms that bleeds easily. Dr. Dawn explains UV radiation damages collagen and elastin, making blood vessels vulnerable to shear forces. She recommends topical vitamin K products like Dermal K and protective lycra sleeves or gardening gauntlets to prevent injuries, emphasizing the need for annual dermatologic exams after extensive sun exposure. An emailer asks about RSV vaccine recommendations before overseas travel. Dr. Dawn disagreed with the couple's physician, citing US Preventive Services Task Force guidelines recommending RSV vaccination for all adults 60 and older, plus those 50+ with chronic conditions. She discusses FDA-approved home testing options including the PIXEL by LabCorp test for COVID, flu, and RSV, and iHealth rapid tests. She notes RSV point-of-care tests are available to medical practitioners and recommends thorough vaccination before international trips. Dr. Dawn presents a frightening investigation into private equity hospital bankruptcies, focusing on Steward Healthcare's 31 hospitals and Prospect's 16 facilities. Private equity firm Cerberus earned $700 million while Steward 650 documented incidents of deficient care including deaths. One woman died from hemorrhage after vendors repossessed equipment due to unpaid bills. She explains the shell game where companies sell hospital land to Medical Properties Trust, forcing new operators to pay rent while private equity extracts profits. The Brookings Institution study reveals systematic prioritization of investor returns over patient care, with courts failing to prevent these practices despite some states passing protective legislation. She discusses stillbirth rates being significantly underreported, with Harvard research showing actual rates of 1 in 147 pregnancies versus CDC's 1 in 175, worsening to 1 in 95 for black families. Over 70% involved known risks like obesity or diabetes, but 30% had no identifiable factors. Dr. Dawn emphasizes unconscious bias in medicine where women's complaints are dismissed, particularly affecting women of color and non-English speakers, noting both patient and provider biases require training to address. Dr. Dawn warns about HPV-related oral squamous cell carcinoma in young men, explaining that changing sexual practices over 30 years have created new transmission routes from genitals to mouth. Major risk factors include smokeless tobacco and hard alcohol which damage DNA. She mentions newly available saliva tests for persistent HPV detection, recommending risk factor reduction for positive cases. She concludes optimistically with a breakthrough Huntington's disease treatment using microRNA molecule AMT-130 delivered via virus to brain striatum. The treatment mirrors toxic Huntington protein's RNA, creating double-stranded structures cells destroy, preventing toxic protein accumulation. The three-year trial of 29 patients showed 75% slowing of disease progression with few side effects, offering hope for 100,000 Americans carrying the mutation, including 40,000 with current symptoms.

In another episode of Carl Ulinski's Building Local Business podcast, electronics whiz Michael Taylor of Tailored Computer Care recounts his journey from self-taught coder and National Guard military police officer to full-time tech troubleshooter.Kicking off as a 2009 side hustle amid deployments and night classes, Taylor hit pause on repairs—until a 2023 epiphany led him to ditch corporate gigs for good. Now thriving in Ilion's Central Plaza (next to LabCorp and Dollar General), he's rebuilt his shop bigger and better, partnering with the Ship & Print store for seamless shipping and printing synergies.

Event marketers talk about personalization a lot. We slap a name on a badge, segment an email list, and call it a day.But attendees want more than that. They want to feel seen: from the first invite, to the way a session is designed, to the follow-up that lands after the show. That's the kind of personalization that creates loyalty, accelerates deals, and turns an event into something people don't forget.That's why on this episode, Jody Hall (Director, Global Event Management at Labcorp) and Michelle Khair (Event Coordinator at Argen Corporation) get real about what's working.Join them as they talk about:✅ How intentional design keeps personalization clear and focused✅ What it means to “architect moments that matter”✅ Where AI supports personalization without replacing the human touchListen in for a conversation that cuts through the noise and shows what true personalization looks like in practice.----------------------------------Connect with ThemJody Hall: https://www.linkedin.com/in/jodyahall/Michelle Khair: https://www.linkedin.com/in/michelle-khair-766066169/Connect with Matt KleinrockLinkedIn: https://www.linkedin.com/in/matt-kleinrock-9613b22b/Company: https://rockwayexhibits.com/

Country Music Drama – Zach Bryan vs. Gavin AdcockIntro:“So there's some major beef in country music right now...”1. Background Context:Fan tweets Zach Bryan asking why he didn't stay to sign autographsZach responds: "Just because you bought a ticket doesn't mean you're entitled to me."The fan turns out to be a 14-year-old kid2. Gavin Adcock Enters the Chat:Gavin calls Zach out publicly: “That's not how you treat your fans”Posts videos purposefully staying after shows to sign autographsSubtle (or not-so-subtle) jabs at Zach3. Festival Confrontation:Both appear at Born & Raised Fest in OklahomaZach (not scheduled) joins another artist on stageZach spots Gavin backstageJumps a barbed wire fence to confront himNearly throws down before security intervenes4. Gavin's Response:Posts video recounting Zach's behaviorSays Zach was drunk, looking for him all day, flipping off people“He wanted to fight an hour before my set — not happening.”Claims Zach would probably sue if hit5. Host Commentary:“Zach's got more to lose”“Let them fight — for charity!”“But really, Zach needs to chill. He's a public figure.”“More people know Gavin now — good press for him.”Final take: “Country music beef this real? Rare. Let's keep watching.” Launa Drama – The Mystery Urine SampleIntro:“Another episode of Launa Drama — you won't believe what happened this time…”1. Launa's Morning:Goes to LabCorp early (5:40 AM!) for bloodworkGets in line, someone cuts ahead — rude!2. The Weird Ask:While waiting, an older woman approaches LanaHands her a sealed urine sample in a plastic bag“Can you drop this off for me? I can't wait.”Launa's reaction: hesitant but agrees out of kindness3. The Chaos:Lab staff refuses to accept the sample from Launa“She has to sign it in herself.”Launa becomes the middle woman in an awkward medical standoffScreams through the store: “Ma'am! Ma'am!”The woman walks out and leaves with the sample4. Host Reactions:Kevin: “You're an accomplice now.”J.R.: “That's shady!”Everyone: “Launa… why did you take it?”Launa: “I was just trying to be nice!”5. PSA Moment:“DO NOT take a stranger's urine sample.”Kevin: “Don't think we needed that PSA, but okay!”See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of Friday Fiduciary Five, Eric Dyson talks about the McDonald v LabCorp lawsuit, focusing on part three and float compensation. He recaps previous episodes on record-keeping fees and investment share classes. The court found the plan's fee monitoring process sufficient. Float income, earned on stale checks, is a plan asset under ERISA, and fiduciaries must ensure it's managed in participants' best interests. Eric advises plan fiduciaries to inquire about float income from record keepers and to review old service agreements. In the LabCorp case, the court concluded that float income was disclosed and monitored appropriately. Eric emphasizes regular benchmarks and RFPs for service providers.Connect with Eric Dyson: Website: https://90northllc.com/Phone: 940-248-4800Email: contact@90northllc.com LinkedIn: https://www.linkedin.com/in/401kguy/ The information contained herein is general in nature and is provided solely for educational and informational purposes.It is not intended to provide a specific recommendation of any type of product or service discussed in this presentation or to provide any warranties, financial advice, or legal advice.The specific facts and circumstances of all qualified plans can vary, and the information contained in this podcast may or may not apply to your individual circumstances or to your plan or client plan's specific circumstances.

In this episode of Friday Fiduciary Five, Eric Dyson talks about the McDonald v. LabCorp ERISA litigation, focusing on investment share classes and collective investment trusts. He highlights that institutional share classes offer lower costs, and LabCorp moved participants to these classes within a reasonable timeframe. Eric emphasizes the importance of exploring collective trusts for plans of all sizes, recommending a thorough analysis to determine eligibility and potential savings. He also addresses the issue of new share classes with short track records, suggesting they be monitored alongside existing ones to ensure similar performance. Connect with Eric Dyson: Website: https://90northllc.com/Phone: 940-248-4800Email: contact@90northllc.com LinkedIn: https://www.linkedin.com/in/401kguy/ The information contained herein is general in nature and is provided solely for educational and informational purposes.It is not intended to provide a specific recommendation of any type of product or service discussed in this presentation or to provide any warranties, financial advice, or legal advice.The specific facts and circumstances of all qualified plans can vary, and the information contained in this podcast may or may not apply to your individual circumstances or to your plan or client plan's specific circumstances.

In this episode of Friday Fiduciary Five, Eric Dyson talks about the LabCorp case, focusing on record-keeping fees. Plaintiffs argued fees should be $20-$25 per person per year, while the plan completed RFIs in 2017, 2019, and benchmarked in 2021 and 2022. The court found the process met the standard of care, though some argue a competitive bid process might have been more effective. Eric emphasizes the importance of fiduciary duty in looking out for participants' best interests. He plans to cover share classes and float income in upcoming episodes, aiming to educate and equip plan sponsors and advisors to improve participant outcomes.Connect with Eric Dyson: Website: https://90northllc.com/Phone: 940-248-4800Email: contact@90northllc.com LinkedIn: https://www.linkedin.com/in/401kguy/ The information contained herein is general in nature and is provided solely for educational and informational purposes.It is not intended to provide a specific recommendation of any type of product or service discussed in this presentation or to provide any warranties, financial advice or legal advice.The specific facts and circumstance of all qualified plans can vary and the information contained in this podcast may or may not apply to your individual circumstances or to your plan or client plan specific circumstances.

Aktien hören ist gut. Aktien kaufen ist besser. Bei unserem Partner Scalable Capital geht's unbegrenzt per Trading-Flatrate oder regelmäßig per Sparplan. Alle weiteren Infos gibt's hier: scalable.capital/oaws. Aktien + Whatsapp = Hier anmelden. Lieber als Newsletter? Geht auch. Das Buch zum Podcast? Jetzt lesen. JD.com will Ceconomy. Puma will Deckers sein. Nestlé will Reckitt sein. Dow will nicht geizig sein. Chipotle, Southwest und American Airlines brauchen Kunden. Labcorp, Charles River Laboratories & West Pharmaceuticals Services haben Kunden. NVIDIA hat Schwarzmarkt. Deutsche Bank (WKN: 514000) hat das beste Quartal seit der Finanzkrise. Wie das und was jetzt? STMicroelectronics (WKN: 893438) schmiert ab. SK Hynix (WKN: 907210) geht durch die Decke. Wie das? Und ist SK Hynix immer noch zu günstig? Diesen Podcast vom 25.07.2025, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung.

Toba Goldstein, LCGC, is a prenatal genetic counselor for Labcorp. She received her bachelor's degree from Drexel University and her masters degree from Arcadia University. In addition to seeing patients for prenatal and preconception genetic counseling, Toba enjoys supervising students, mentoring new graduates, and teaching high school students about genetic counseling as a career opportunity. Toba lives in Bala Cynwyd, PA with her husband and three children.   CONNECT WITH DVORA ENTIN: Website: https://www.dvoraentin.com/ Instagram: https://www.instagram.com/dvoraentin YouTube: https://www.youtube.com/@misconceptionspodcast  

After some feedback and further thoughts on our Skrmetti episode and a shocking revelation about "LabCorp," we circle back to an earlier June opinion about religious distinctions, Catholic Charities Bureau v. Wisconsin Labor & Industry Review Commission. Dan keeps Will up past his bedtime.

Stepping outside your comfort zone can shape your career in unexpected and rewarding ways. That's exactly what Jenny Hofler, Director, Early Career Recruiting, Global Talent Acquisition at Labcorp has done — and now she's building opportunities for early career talent at a global scale. On this episode, she joins host Ryan Dull, and they discuss how Jenny's journey from a communications graduate to a TA leader has informed her passion for early talent and inclusive hiring.Key Takeaways:(02:33) Jenny's non-traditional entry into talent acquisition.(04:20) Her transitions across Fidelity, MetLife, AWS and eventually to Labcorp.(06:37) An overview of Labcorp's global presence and mission.(07:59) Internships across the globe — from the US to Singapore and Bulgaria.(10:00) Enhancing internal and external communications around early talent.(13:34) Leveraging data to improve conversion, diversity and retention.(15:40) Taking ownership of the internship experience beyond recruitment.(16:51) What's next: evolving internship programming and university outreach.(18:34) Advice for job seekers and those transitioning into TA.(20:05) TA professionals inspire creativity, perseverance, and growth.Resources Mentioned:Jenny Hoflerhttps://www.linkedin.com/in/jennyhoflerlovestalent/Labcorp | LinkedInhttps://www.linkedin.com/company/labcorp/Labcorp | Websitehttps://www.labcorp.com/This episode is brought to you by Sagemark HR.Sagemark HR can help you:✔ Improve your talent practices and make better, more informed people decisions.After 20+ years of experience leading Recruiting and Talent Acquisition across a wide variety of industries, I've seen enough hires (over 100,000 to date) to know that hiring decisions truly can make or break an organization.✔ Identify opportunities to not only improve your talent practices, but also delivering tangible business results.We understand every organization is different, and there's no one-size-fits-all magic solution. So we listen first and identify the gaps and sticking points in your current process before ever recommending a solution.✔ Bridge the gap from “traditional” to modern recruiting, without the painful learning curve.We believe recruiting, talent, and HR technology is a deep well of untapped business potential, and our mission is to help you identify and implement those hiring tools in a way that works for you.If you're interested in learning more, you can reach me at:www.sagemarkhr.com✉ ryan.dull@sagemarkhr.com#Talent #Recruiters #Recruiting #HRTech

In this powerful episode of the Tick Boot Camp Podcast, we welcome Austin Shubert, a 27-year-old outdoorsman, hunter, and field technician from Zebulon, Georgia. He shares his deeply personal and emotional journey from vibrant health to chronic illness and back toward recovery. Raised in the woods, surrounded by ticks since childhood, Austin never imagined that a single tick bite could change his life.

How can you create a people strategy that aligns to and drives your business strategy? What is a People P&L and why does your organization need one?My guest on this episode is Anita Graham, EVP & CHRO for Labcorp. During our conversation Anita and I discuss:Why taking initiative matters for your career and how early-career professionals can develop this skill.Why you should be intentional with your career choices but remain open to unexpected opportunities.How to build an aligned and high-performing HR leadership team.Why you need a 'People P&L' and the impact it can have on your business.Why you should think about your HR strategy in 3-5 year timeframes. Connecting with Anita: Connect with Anita Graham on LinkedInEpisode Sponsor: Next-Gen HR Accelerator - Learn more about this best-in-class leadership development program for next-gen HR leadersHR Leader's Blueprint - 18 pages of real-world advice from 100+ HR thought leaders. Simple, actionable, and proven strategies to advance your career.Succession Planning Playbook: In this focused 1-page resource, I cut through the noise to give you the vital elements that define what “great” succession planning looks like.

We start out by debating who's responsible for Dan's audio snafus last time before digging into a various odds and ends, such as the Chief Justice's toast at the Supreme Court Historical Society dinner and President Trump's renunciation of Leonard Leo and the Federalist Society. We then try to make sense of the DIG in Labcorp v. Davis and see whether our predictions about Smith & Wesson Brands, Inc. v. Estados Unidos Mexicanos panned out. 

In this episode of the Becker's Healthcare Podcast, Brian Zimmerman speaks with Dr. Mindy Nye, Vice President at Labcorp, about the evolving role of diagnostic laboratory science and how innovation is transforming patient care. Dr. Nye explores the meaning of “diagnostic innovation,” the technologies reshaping lab capabilities, and how these advancements are creating new value for health systems. Tune in for expert insights on why the clinical lab is becoming an increasingly strategic asset in modern healthcare.This episode is sponsored by labcorp.

In this episode of The Patient From Hell, host Samira Daswani speaks with oncology pharmacist Megan Hartranft about the critical role of oncology pharmacists in cancer care. They discuss the unique responsibilities of oncology pharmacists, the importance of patient education, and the growing field of oral chemotherapy. Megan shares insights on medication adherence, the use of mobile health technologies, and the significance of symptom management in improving patient outcomes. The conversation highlights the need for better integration within healthcare systems and offers practical tips for patients navigating their treatment journey.About Our Guest:Dr. Megan Hartranft is a Clinical Lead with the Clinical and Digital Solutions team, advising on precision oncology products.Prior to joining Labcorp, Dr. Hartranft was a Field Medical Scientific Associate Director at Sanofi, in charge of training for the hematology-oncology medical science liaison team. Earlier as a practicing clinician, she established an oral chemotherapy education program and participated in interprofessional clinics at Rush University Cancer Center. She has also spent time in academia as the oncology faculty member at Rosalind Franklin University of Medicine and Health Sciences, where she maintains an adjunct appointment. Dr. Hartranft is active in several professional organizations, including her roles on the Hematology Oncology Pharmacy Association's Public Policy & Advocacy Committee as well as the American Society of Health System Pharmacy Section of Pharmacy Informatics and Technology Clinical Decision Support and Analytics Advisory Group.BS in Biochemistry/Molecular Biology and BA in Classical Studies - Michigan State University Doctor of Pharmacy - University of North Carolina at Chapel Hill PGY1 Pharmacy Residency - University of Michigan PGY2 Oncology Specialty Residency - University of Georgia/Augusta University Health SystemResources & Links:This episode was supported by the Patient Centered Outcomes Research Institute (PCORI) and features the PCORI research study here: https://pubmed.ncbi.nlm.nih.gov/30964... ‘Integrating Advance Care Planning Videos into Surgical Oncologic Care: A Randomized Clinical Trial'00:00 Introduction to Oncology Pharmacy02:49 The Role of Oncology Pharmacists in Patient Care06:03 Patient Interaction and Education09:09 Exploring Oral Chemotherapy11:45 Adherence to Oral Anti-Cancer Medications15:01 Mobile Health Technologies in Oncology17:58 Symptom Management and Patient Support21:11 The Future of Oncology Pharmacy24:09 Final Thoughts and Tips for PatientsConnect with Us:Enjoyed this episode? Make sure to subscribe, rate, and review! Follow us on Instagram, Facebook, or Linkedin @mantacares and visit our website at mantacares.com for more episodes and updates.Listen Elsewhere: Website: https://mantacares.com/pages/podcast?... YouTube: https://www.youtube.com/@mantacares Spotify: https://open.spotify.com/episode/3TR1... Apple: https://podcasts.apple.com/us/podcast... Disclaimer:All content and information provided in connection with Manta Cares is solely intended for informational and educational purposes only. This content and information is not intended to be a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.This episode was supported by an award from the Patient-Centered Outcomes Research Institute.

Join our community of RE investors on Skool here: https://www.skool.com/the-real-estate-investing-club-5101/about?ref=44459ba83f5540f19109c8a530db4023FROM CALL CENTERS TO CASH FLOWIn this eye-opening episode of The Real Estate Investing Club, I sit down with Dave Codrea, co-founder of Greenleaf Capital Partners, who reveals an innovative investment strategy that perfectly captures today's changing commercial landscape: repurposing vacant call centers into thriving multi-tenant business spaces.

In this episode of the Findaway Podcast, Dusty discusses the next step in his health journey—getting his biomarkers and testosterone levels checked. He explains that he partnered with HONE Health to undergo blood work, as he wants to better understand his hormone levels, especially after turning 40 and having two kids.Key Takeaways: • Why Check Biomarkers? • Hormones play a significant role in overall health, weight management, muscle building, and energy levels. • Factors like aging, parenting, and lifestyle changes can impact hormone levels, including testosterone. • Dusty has never had his testosterone levels checked before and wants to see if optimization is needed. • Concerns About Testing & Gimmicks • A follower raised concerns about health companies being gimmicky. • Dusty reassures that he is sharing his journey transparently, not promoting a product blindly. • He acknowledges skepticism but believes in the importance of getting hormone levels checked. • Testosterone & Its Effects • Lower testosterone can make weight management and muscle-building harder. • Hormonal imbalances can affect metabolism, energy, and how the body responds to food and exercise. • He mentions his wife's experience with PCOS, emphasizing how hormone imbalances can make weight loss more challenging. • The Testing Process • Bloodwork was done at home via a LabCorp professional. • He expects to receive results soon and will share them openly. • If levels are normal, he'll accept the natural shifts that come with age and life changes. If not, he'll explore potential solutions. • The Value of Sharing the Journey • Dusty reflects on how he originally didn't share his weight loss journey out of fear of failure. • He sees value in sharing the in-between moments rather than just before-and-after results. • He hopes this process helps others understand the importance of hormone health.Final Thoughts:Dusty is waiting for his test results and will share what he learns. Whether or not his testosterone needs optimization, he sees this as an opportunity to educate others on hormone health and how it impacts fitness and well-being.

Hear from rheumatologist Stanley J. Naides MD, FACP, FACR, as he details the clinical features of autoimmune myositis, the associated phenotypes and autoantibodies, plus the methodologies and testing options to support a myositis diagnosis.

Episode 2615: In this Call-In show, Vinnie Tortorich and Chris Shaffer speak to callers about making progress, having goals, and more.  https://vinnietortorich.com/2025/03/making-progress-having-goals-episode-2615 PLEASE SUPPORT OUR SPONSORS YOU CAN WATCH ALL THE PODCAST EPISODES ON YOUTUBE - Making Progress and Having Goals Vinnie used to do speeches at events, but that has changed since COVID. (2:00) He's considering doing shows again and bounces ideas off of Chris. Charles is the first caller, and after chatting about skiing, Charles gives an update on his progress. He said he's had an epiphany about his activity level and poor knees. Charles is diabetic and wears a CGM and NSNG® has helped him recalibrate his glucose. Mark, the second caller, and Vinnie discuss hiking the Appalachian Trail and the Santiago Trail in Spain. (39:00) They are interesting hikes, and you develop relationships because of the sense of community. Mark is also concerned about his cholesterol, but his doctor doesn't appear knowledgeable about the current science. (54:00) Vinnie suggests reaching out to many of the doctors he has had on his show. Chris suggests that Mark use LabCorp, which does independent testing, often for a reasonable fee. More News If you are interested in the NSNG® VIP group, closed for registration, but you can get on the wait list - Don't forget to check out Serena Scott Thomas on Days Of Our Lives on the Peacock channel.  “Dirty Keto” is available on Amazon! You can purchase or rent it . Make sure you watch, rate, and review it! Eat Happy Italian, Anna's next cookbook is available!  You can go to You can order it from . Anna's recipes are in her cookbooks, website, and Substack–they will spice up your day! Don't forget you can invest in Anna's Eat Happy Kitchen through StartEngine.  Details are at Eat Happy Kitchen. There's a new NSNG® Foods promo code you can use! The promo code ONLY works on the NSNG® Foods website, NOT on Amazon. https://nsngfoods.com/ [the_ad id="20253"] PURCHASE  DIRTY KETO (2024) The documentary launched in August 2024! Order it TODAY! This is Vinnie's fourth documentary in just over five years. Visit my new Documentaries HQ to find my films everywhere: Then, please share my fact-based, health-focused documentary series with your friends and family. Additionally, the more views, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! PURCHASE BEYOND IMPOSSIBLE (2022) Visit my new Documentaries HQ to find my films everywhere: REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! FAT: A DOCUMENTARY 2 (2021) Visit my new Documentaries HQ to find my films everywhere: FAT: A DOCUMENTARY (2019) Visit my new Documentaries HQ to find my films everywhere:

Why DHEA is the Most Important Hormone in Your Bodyhttps://www.drhughwegwerth.com/post/dhea-for-men-and-women-how-it-boosts-testosteroneHost: Dr. Hugh WegwerthAre you feeling sluggish, struggling with mood swings, or noticing changes in your body as you age? It could be your hormones!In this episode, Dr. Hugh dives deep into DHEA, the most abundant hormone in your body and a key player in your health. Learn why keeping DHEA at optimal levels is essential and how it affects everything from testosterone to brain function.What You'll Learn in This Episode:What is DHEA?The #1 most abundant hormone in your bodyWhy DHEA is more important than testosterone and progesteroneHow DHEA Impacts Your HealthConverts into testosterone and estrogenSupports brain health, memory, and moodHelps reduce inflammationAging & HormonesHow DHEA levels drop as you get olderWhy maintaining healthy hormone levels improves skin, muscle tone, and energyTesting & Supplementing DHEAWhy you must test, not guess before taking DHEAHow you can get tested easily at LabCorp for as little as $10How to read your results and where your levels should beDHEA plays a critical role in your body's overall function—and you might be missing out on its benefits! Tune in to learn how you can optimize your DHEA levels for better energy, mental clarity, and a higher quality of life.

What's the protocol for hyperthyroidism with Graves' disease and H. pylori? How many cruciferous vegetables can you eat if you have hypothyroidism? For a person with Graves' disease, is it possible to get the antibodies to zero? How do you treat leaky gut?Today, I'm back with another Q&A episode, answering multiple questions submitted by the Save My Thyroid community. While I can't get to everyone's questions every time, I love creating these for you, and I'll do similar episodes every couple of months. You can also check out my YouTube Channel at SaveMyThyroid.com/YouTube for more answers to your questions. Please share your questions with me by emailing info@naturalendocrinesolutions.com, and I'll include the most relevant ones in upcoming episodes.In this episode, I'm answering:Q1: I have two toxic nodules on the left side. Can they shrink and repair themselves with herbal supplements?Q2: How many people have you seen that reversed Hashimoto's and no longer needed medication?Q3: What's the protocol for hyperthyroidism with Graves' disease and H. pylori?Q4: How many cruciferous vegetables can you eat daily if you have hypothyroidism or Hashimoto's?Q5: For a person with Graves' disease, is it possible to get the antibodies to zero? If yes, what can help to keep them at zero?Q6: My TPO on my LabCorp labs is < 9, my thyroglobulin is 18, and my TPO antibodies are negative. Do I have Hashimoto's?Q7: Do you recommend sea moss for Graves' disease?Q8: Is there any relationship between Hashimoto's and EPI (exocrine pancreatic insufficiency)?Q9: What are the best foods and supplements to get back to balance your Graves' or hyperthyroid state? Is it possible to reverse?Q10: Dealing with hypothyroidism, and when I went to my standard medical care endocrinologist, he wanted me to stop all mainstream supplements except fish oil. Why is that?Q11: My lab results for TSH, free T4, and free T3 are normal, and I am taking 7.5 mg of methimazole. Can I stop the medication and start the natural path of healing antibodies, or can I combine both?Q12: For those of us who have been on thyroid meds for over a decade, what is the likelihood we have damaged our thyroid beyond being able to get off the meds?Q13: How do you treat leaky gut?Q14:  I've been diagnosed with Hashimoto's in April 2023 but had hypothyroidism in January. At the end of October 2023, I started losing weight. Do you meet people like me who have been losing weight with hypothyroidism and Hashimoto's?Q15: What are hidden sources of iodine that someone with Graves' may not think of other than clearly marked iodized salt?Q16: When taking NP Thyroid, can you take it with warm lemon juice, which has many benefits, instead of plain water?And more.As always, I hope you find this episode valuable, and I look forward to catching you in the next episode!To learn more, visit the show notes at https://savemythyroid.com/podcast/your-thyroid-questions-answered-part-2-jan-2025/.To register for the Healthy Gut Healthy Thyroid Bootcamp visit www.savemythyroid.com/healthygut Do You Want Help Saving Your Thyroid? Access hundreds of free articles at www.NaturalEndocrineSolutions.com Visit Dr. Eric's YouTube channel at www.youtube.com/c/NaturalThyroidDoctor/ To work with Dr. Eric, visit https://savemythyroid.com/work-with-dr-eric/

Tune in as Dr. Mahul Amin, from Labcorp, discusses the evolving landscape of diagnostic testing, the impact of lab medicine on health systems, and future innovations that promise to shape the field, providing valuable insights for healthcare leaders.This episode is sponsored by Labcorp.

Jesse Solomon (@jessesols) is the breakout star of Bravo's Summer House Season 8, who has captured the hearts of America and has them pondering "WWJSD" (What Would Jesse Solomon Do). Originally from Chicago, Jesse worked in finance before being discovered.  As a natural born entertainer, he now splits his time between New York and Miami, pursuing his love for music, hosting, fitness, wellness, and bringing people together.  Not only is he known for approaching every girl in the bar with a charming smile and clever banter, but Jesse is also a two-time cancer survivor who shares his story of resilience with a lighthearted outlook on life.  He recently filmed Season 9, launched a new single "WWJSD," and is expanding his online presence by collaborating with brands like Amazon (@amazon), GoPuff (@gopuff), Celsius (@celsiusofficial), and LabCorp (@labcorp). Through his infectious energy and genuine love for life, Jesse is building a digital family while spreading positivity and gratitude. EPISODE OVERVIEW: 0:06:10 Introduction of Jesse Solomon 0:07:45 Jesse Solomon's career journey 0:21:19 His transition to Reality TV and personal growth 0:22:24 Jesse opens up about his cancer diagnosis in 2017 and the initial fear and shock he felt. 0:31:25 Building a personal brand and business 0:41:01 Balancing multiple roles and prioritizing time 0:45:32 The importance of clean eating and getting enough hours of sleep.  0:51:46 Jesse shares the importance of being selective and finding a high-quality partner. 0:56:46 Jesse's future plans of potential projects and growing his personal brand.  & SO much more! Share the love & let me know your thoughts over on Instagram,⁠  @coffeeandagoodvibe  | @ayeshasehra⁠ EPISODES MENTIONS: Amazon, GoPuff, Celsius, LabCorp Follow Jesse Solomon on | ⁠Tiktok⁠ |  Instagram Listen to The Jesse Solomon Show Podcast on ⁠Apple⁠ | ⁠Spotify⁠ |⁠PodBay To learn more about WWJSD , click⁠ HERE⁠ WATCH THE FULL VIDEO INTERVIEWS ON YOUTUBE ➟ Watch & subscribe to our channel here ➟ ⁠Coffee & A Good Vibe Video Interviews ⁠ To connect with Ayesha Sehra ➟ click⁠ HERE⁠ Check out our podcast Insta ➟ click ⁠HERE⁠  To learn about my PR Agency Grow The Social ➟ click ⁠HERE ⁠